Mask biological evaluation testing verifies that medical face masks, surgical masks, and respiratory protective devices are biologically safe for skin contact, covering cytotoxicity, skin irritation, and sensitization endpoints defined by the ISO 10993 series of standards. Performed by accredited third-party laboratories, these tests are a mandatory component of regulatory submissions under the EU MDR, US FDA 510(k) process, and NMPA registration schemes. This article explains the evaluation framework, sample requirements, test methods, and practical considerations for mask manufacturers.
Technical Overview
Medical face masks and respirators are classified as surface-contacting medical devices that contact intact skin for a duration ranging from limited contact (up to 24 hours) to prolonged contact (24 hours to 30 days). Under ISO 10993-1, the biological evaluation of such devices must be conducted within a risk management process, typically aligned with ISO 14971, and documented in a biological evaluation plan and a biological evaluation report prepared or reviewed by a qualified toxicologist.
For skin-contacting devices of this category, the ISO 10993-1 endpoint matrix identifies three core biological endpoints: cytotoxicity, irritation, and sensitization. These form the standard "biocompatibility trio" required for mask biocompatibility files. In China, the GB/T 16886 series adopts the ISO 10993 standards directly, so a test report generated to ISO 10993 methods is generally acceptable under GB/T 16886 as well.
Depending on the risk assessment, supplementary chemical characterization per ISO 10993-18 and toxicological risk assessment per ISO 10993-17 may be added, particularly for masks containing dyes, adhesives, antimicrobial coatings, or activated carbon layers. Biological evaluation results are typically submitted alongside product performance testing to standards such as EN 14683, ASTM F2100, or GB 19083 as part of the complete technical documentation.
Testing Samples
Mask Body and Filter Layers
The primary test article is the mask body, typically consisting of spunbond and melt-blown polypropylene nonwoven layers or SMS composite structures. All layers that contact facial skin, either directly or through the innermost layer, must be represented in the test extracts.
Nose Bars, Nose Foam, and Adhesives
Metal or plastic-coated nose strips, polyurethane nose foam padding, and hot-melt or water-based adhesives are skin-contacting components that must be included in the biological evaluation, since metallic ions, residual monomers, or adhesive constituents may migrate during prolonged wear.
Head Straps and Ear Loops
Elastic straps made of spandex, nylon, or polyester blends contact the skin behind the ears or around the head for extended periods and are treated as integral components of the test article rather than separate accessories.
Finished Device Versus Material Coupons
Testing on the finished, sterilized or fully processed device is preferred because it captures manufacturing residues, cutting fluids, and converting processes. Material coupons may be used for early screening, but final regulatory submissions generally require extracts from the finished product in its as-delivered state. A typical three-test panel requires approximately 20 to 40 finished masks or sufficient material to provide at least 1,200 square centimeters of contact surface area per extraction vehicle.
Testing Items
The standard biological evaluation panel for medical face masks includes the following items, selected according to the ISO 10993-1 matrix for surface devices contacting intact skin:
- Cytotoxicity testing in accordance with ISO 10993-5 and GB/T 16886.5
- Skin irritation and intracutaneous reactivity testing in accordance with ISO 10993-10, ISO 10993-23, and GB/T 16886.10 or GB/T 16886.23
- Skin sensitization testing in accordance with ISO 10993-10 and GB/T 16886.10
- Acute systemic toxicity per ISO 10993-11, only when justified by the risk assessment for masks with novel functional coatings
- Chemical characterization of extractables per ISO 10993-18, combined with a toxicological risk assessment per ISO 10993-17, as a supporting or alternative data stream
For conventional polypropylene masks without functional coatings, the three-item panel of cytotoxicity, irritation, and sensitization is generally accepted as sufficient by notified bodies and regulators for surface devices with intact-skin contact.
Testing Methods
Sample Preparation and Extraction (ISO 10993-12)
All tests begin with extraction of the test article following ISO 10993-12. Mask materials are cut into sections and extracted at a standard surface-area-to-volume ratio, commonly 6 square centimeters per milliliter for materials thicker than 0.5 millimeters and 3 square centimeters per milliliter for thinner films. Both a polar vehicle (physiological saline or cell culture medium) and a non-polar vehicle (such as sesame seed oil) are used where the method requires dual extraction. Standard extraction conditions include 37 degrees Celsius for 72 hours, 50 degrees Celsius for 72 hours, or 70 degrees Celsius for 24 hours, with the condition selected to simulate or exaggerate clinical exposure without degrading the polymer.
In Vitro Cytotoxicity (ISO 10993-5)
The most widely applied method is the extract, or elution, assay using L929 mouse fibroblast cultures. Test articles are extracted in minimal essential medium supplemented with serum, the extract is applied to confluent cell monolayers, and cells are incubated for 24 to 48 hours. Results are evaluated qualitatively by microscopic grading of morphological changes on a 0 to 4 reactivity scale and quantitatively by a colorimetric viability assay such as MTT or neutral red uptake. The acceptance criterion is a cell viability of at least 70 percent relative to the blank control and a qualitative reactivity grade not exceeding 2.
Skin Irritation and Intracutaneous Reactivity (ISO 10993-10 and ISO 10993-23)
The classical approach is the rabbit intracutaneous reactivity test, in which polar and non-polar extracts are injected intradermally at multiple sites. Erythema and edema are scored at 24, 48, and 72 hours, and the device passes when the difference between the mean test and control scores does not exceed 1.0 for each extract. ISO 10993-23 also recognizes in vitro alternatives using reconstructed human epidermis tissue models, which support animal-free assessment of irritation and are increasingly accepted when validated for the device type.
Skin Sensitization (ISO 10993-10)
Sensitization potential is evaluated using the guinea pig maximization test, which combines intradermal and topical induction followed by a topical challenge, or the closed-patch Buehler method, which is particularly relevant for skin-contact devices. The murine local lymph node assay is also permitted under ISO 10993-10 and offers reduced animal use with objective proliferation-based endpoints. Test outcomes are scored against vehicle controls, and any observed response must be below the threshold for a sensitization reaction to declare the mask non-sensitizing.
Evaluation Strategy and Animal Welfare
In accordance with ISO 10993-2, testing programs should apply the principles of replacement, reduction, and refinement. Where existing literature, material characterization data, or a documented history of safe use of identical polypropylene materials is available, a biological evaluation report may justify waiving certain in vivo endpoints, shortening timelines and reducing animal use.
Applications
Biological evaluation reports for masks serve multiple regulatory and commercial purposes:
- CE marking under the EU Medical Device Regulation, where the biological evaluation file is a mandatory element of the technical documentation reviewed by the notified body
- US FDA 510(k) submissions for surgical masks and pediatric masks, which require a full biocompatibility panel or a robust justification based on ISO 10993-1
- NMPA registration in China, where testing to the GB/T 16886 series by a qualified laboratory is expected for medical device filing
- Support for product performance certifications under EN 14683, ASTM F2100, and GB 19083, where biocompatibility complements bacterial filtration efficiency and differential pressure testing
- Design change verification, supplier changes of nonwoven or elastic materials, and new dye or coating introductions during product development
- Buyer verification, tender documentation, and post-market surveillance responses requested by distributors and health authorities
FAQ
Which biological tests are mandatory for medical face masks?
For masks contacting intact skin, the core panel is cytotoxicity (ISO 10993-5), irritation or intracutaneous reactivity (ISO 10993-10 or ISO 10993-23), and sensitization (ISO 10993-10). Additional endpoints are only required when the risk assessment identifies specific concerns, such as novel coatings or adhesives.
How many masks are needed for a full test panel?
Most laboratories request 20 to 40 finished masks in final packaging to cover the three-test panel, including extract preparation for both polar and non-polar vehicles. Exact quantities depend on mask size and the laboratory's validated procedures, so the protocol should be confirmed before sampling.
How long does mask biological evaluation testing take?
Cytotoxicity typically requires 2 to 3 weeks, intracutaneous irritation 3 to 4 weeks, and sensitization 6 to 10 weeks depending on the method selected. A complete panel with the final evaluation report is commonly delivered within 8 to 12 weeks.
Can animal testing be avoided?
Partially. Cytotoxicity is entirely in vitro, and in vitro skin irritation models under ISO 10993-23 can replace the rabbit test when appropriate for the device. Sensitization still generally relies on animal methods, although chemical characterization combined with toxicological risk assessment per ISO 10993-17 and ISO 10993-18 can sometimes justify waiving in vivo sensitization for well-characterized materials.
Do N95 or KN95 respirators require the same biological evaluation?
When marketed as medical devices or medical-use protective respirators, they are subject to the same ISO 10993-1 endpoint logic as surgical masks, and the three-test panel applies. Respirators sold exclusively as personal protective equipment may instead fall under PPE regulatory frameworks, though skin safety data is frequently requested by buyers regardless.
How often should biological evaluation be repeated?
Biological evaluation must be reviewed whenever materials, suppliers, manufacturing processes, or surface treatments change. In the absence of changes, a documented periodic review of the biological evaluation report, typically every one to two years, is sufficient to maintain regulatory compliance.